Cure My Disease

Don't miss your cure!

 Log in / Sign up

New blood and tissue test could spot High-Risk lung cancer patients early

NCT ID NCT05557474

Recruiting now Diagnosis Sponsor: Chung Shan Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing two new diagnostic kits that use blood samples or tumor tissue to predict if early-stage lung cancer will come back after surgery. Researchers will enroll 236 people with stage IA to IIIA lung cancer who have had their tumor fully removed. The goal is to see if these kits can accurately identify patients at higher risk of recurrence, which could help doctors decide on additional treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ELISA and IHC diagnostic kits
What this could lead to
If successful, this could help doctors identify which early-stage lung cancer patients are at high risk of recurrence, enabling more tailored follow-up and treatment.
What could go wrong
This is a relatively small, single-center study focused on diagnostic accuracy, not a treatment. The kits may not prove reliable enough for widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung adenocarcinoma lung cancer lung neoplasm Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER RECURRENCE SURGERY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chung Shan Medical University Hospital

    RECRUITING

    Taichung, Taiwan, 402, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Taiwan University, Cancer Center

    RECRUITING

    Taipei, 106, Taiwan

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.